These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17213249)

  • 21. The agony with ecstasy: lessons from a recent rave.
    Hoo GW
    J Intensive Care Med; 2013; 28(4):259-61. PubMed ID: 22914795
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ecstasy, new psychotropic drugs].
    Djezzar S
    Soins Psychiatr; 2009; (262):35-7. PubMed ID: 19579485
    [No Abstract]   [Full Text] [Related]  

  • 23. Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.
    Bedi G; Redman J
    J Psychopharmacol; 2006 May; 20(3):432-6. PubMed ID: 16574718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescence and alcohol: recent advances in understanding the impact of alcohol use during a critical developmental window.
    Matthews DB
    Alcohol; 2010 Feb; 44(1):1-2. PubMed ID: 20113869
    [No Abstract]   [Full Text] [Related]  

  • 25. Benzylpiperizine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amphetamines, cocaine, and alcohol.
    Theron L; Jansen K; Miles J
    N Z Med J; 2007 Feb; 120(1249):U2416. PubMed ID: 17308553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecstasy substance abuse.
    Nowicke CE
    Crit Care Nurse; 2004 Apr; 24(2):16. PubMed ID: 15098306
    [No Abstract]   [Full Text] [Related]  

  • 27. The dangerous professor.
    Kupferschmidt K
    Science; 2014 Jan; 343(6170):478-81. PubMed ID: 24482461
    [No Abstract]   [Full Text] [Related]  

  • 28. MDMA (Ecstasy) use and psychiatric problems.
    Guillot CR; Berman ME
    Psychopharmacology (Berl); 2007 Jan; 189(4):575-6. PubMed ID: 17061108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Arthritis after ecstasy consumption].
    Duró JC; Monfort J; Farré M
    An Med Interna; 2001 Sep; 18(9):503-4. PubMed ID: 11715146
    [No Abstract]   [Full Text] [Related]  

  • 30. The politics of Ecstasy.
    Grob CS
    J Psychoactive Drugs; 2002; 34(2):143-4. PubMed ID: 12691204
    [No Abstract]   [Full Text] [Related]  

  • 31. Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises.
    Caulkins JP; Reuter P; Coulson C
    Addiction; 2011 Nov; 106(11):1886-90. PubMed ID: 21895823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    Wilkins C; Sweetsur P
    N Z Med J; 2008 May; 121(1274):61-71. PubMed ID: 18535647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rave drugs: pharmacological considerations.
    Hornfeldt CS
    AANA J; 2004 Oct; 72(5):334-5; author reply 335. PubMed ID: 15529726
    [No Abstract]   [Full Text] [Related]  

  • 36. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention.
    Leach JP; Mohanraj R; Borland W
    Epilepsia; 2012 Sep; 53 Suppl 4():48-57. PubMed ID: 22946721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of forced alcoholization on establishment of hierarchial relations in rats].
    Filatova EV; Egorov AIu; Shnitko TA; Afanas'ev SV
    Zh Evol Biokhim Fiziol; 2008; 44(4):443-5. PubMed ID: 18767563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.